Cost-effectiveness analysis of the use of faricimab in diabetic macular edema in China
Aim: Diabetic macular edema (DME) is one of the leading causes of vision impairment in diabetic patients. The aim of this study was to evaluate the cost-effectiveness of faricimab (Vabysmo R ), the first bispecific antibody targeting VEGF-A and ANG-2, for treating DME in China. Materials & method...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Becaris Publishing Limited
2026-03-01
|
| Schriftenreihe: | Journal of Comparative Effectiveness Research |
| Schlagworte: | |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|